Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Abivax (ABVX) Return on Capital Employed (2025)

Historic Return on Capital Employed for Abivax (ABVX) over the last 1 years, with Q3 2025 value amounting to 0.68%.

  • Abivax's Return on Capital Employed changed N/A to 0.68% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.68%, marking a year-over-year change of. This contributed to the annual value of 0.99% for FY2024, which is 1700.0% up from last year.
  • According to the latest figures from Q3 2025, Abivax's Return on Capital Employed is 0.68%.
  • Abivax's 5-year Return on Capital Employed high stood at 0.68% for Q3 2025, and its period low was 7.17% during Q2 2025.